You are here » Home » Markets » Stocks » Announcements

ANNOUNCEMENTS

Announcement for "Alkem Laboratories Ltd"

Alkem Laboratories Ltd Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations 2015 for Quarter ended D

  • 11/01/2017
  • |
  • bse

Alkem Laboratories Ltd Closure of Trading Window

  • 29/12/2016
  • |
  • bse

Alkem Laboratories Ltd Alkem receives EIR from the US FDA for its Daman formulation facility

  • 23/12/2016
  • |
  • bse

Alkem Laboratories Ltd Update on US FDA Inspection at Alkem?s Ankleshwar API Facility

  • 12/12/2016
  • |
  • bse

Alkem Laboratories Ltd Fixes Record Date for Interim Dividend

  • 11/11/2016
  • |
  • bse

Alkem Laboratories Ltd Opening of Trading Window

  • 11/11/2016
  • |
  • bse

Alkem Laboratories Ltd Board declares Interim Dividend

  • 11/11/2016
  • |
  • bse

Alkem Laboratories Ltd Standalone & Consolidated Financial Results Limited Review Report for September 30 2016

  • 11/11/2016
  • |
  • bse

Alkem Laboratories Ltd Intimation of Conference Call on Q2 FY17 Results

  • 07/11/2016
  • |
  • bse

Alkem Laboratories Ltd Update on the US FDA Bio-analytical Inspection at Alkem?s Daman Facility

  • 28/10/2016
  • |
  • bse

Alkem Laboratories Ltd Board to consider Interim Dividend

  • 28/10/2016
  • |
  • bse

Alkem Laboratories Ltd Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations 2015 for Quarter ended S

  • 13/10/2016
  • |
  • bse

Alkem Laboratories Ltd Update on US FDA Inspection at Alkem?s Daman Facility

  • 29/09/2016
  • |
  • bse

Alkem Laboratories Ltd Closure of Trading Window

  • 28/09/2016
  • |
  • bse

Alkem Laboratories Ltd Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations 2015)

  • 03/09/2016
  • |
  • bse

Alkem Laboratories Ltd Outcome of Board Meeting

  • 12/08/2016
  • |
  • bse

Alkem Laboratories Ltd Opening of Trading Window

  • 12/08/2016
  • |
  • bse

Alkem Laboratories Ltd Press Release and Analyst presentation on Q1FY17 Results

  • 12/08/2016
  • |
  • bse

Alkem Laboratories Ltd Standalone & Consolidated Financial Results Limited Review Report for June 30 2016

  • 12/08/2016
  • |
  • bse

Alkem Laboratories Ltd Successful US FDA Inspection at Alkems Bioequivalence Facility at Taloja

  • 11/08/2016
  • |
  • bse